HCV genotype 2 as a risk factor for reactivation in patients with B-cell lymphoma undergoing rituximab combination chemotherapy: Correspondence

British Journal of Haematology

Volumn 150, Issue 1, 2010, Pages 116-117

  Pitini, Vincenzo ^a   Sturniolo, Giuseppe ^a   Arrigo, Carmela ^a   Leonardi, Silvana ^a   Pino, Salvatrice ^a   Altavilla, Giuseppe ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

CD20 positive B cell lymphoma; HCV; Rituximab

Indexed keywords

ALANINE AMINOTRANSFERASE; CD20 ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISOLONE; RITUXIMAB; VINCRISTINE; VIRUS RNA;

AGED; ASCITES; B CELL LYMPHOMA; B LYMPHOCYTE; CANCER GROWTH; CASE REPORT; DECOMPENSATED LIVER CIRRHOSIS; EDEMA; FEMALE; FOLLICULAR LYMPHOMA; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LETTER; LIVER FUNCTION; LYMPHOCYTE DEPLETION; MALE; MULTIPLE CYCLE TREATMENT; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; REMISSION; RISK FACTOR; VIRUS LOAD; VIRUS REACTIVATION;

EID: 77953531899     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2010.08154.x     Document Type: Letter

References (6)

1. Coppola, N., Vatiero, L.M. Sagnelli, E. (2005) HCV genotype 2 as a risk factor for reactivation of chronic HCV infection. Gut, 54, 1207.
2. Hiraga, N., Suzuki, F., Akuta, N., Suzuki, Y., Sezaki, H., Hosaka, T., Someya, T., Kobayashi, M., Saitoh, S., Arase, Y., Ikeda, K., Kobayashi, M., Matsuda, M., Watabiki, S., Satoh, J. Kumada, H. (2005) Clinical and virological characteristics of untreated patients with chronic hepatitis C who develop serum alanine aminotransferase flare-up. Journal of Medical Virology, 75, 240 248.
3. Lake-Bakaar, G., Dustin, L., McKeating, J., Newton, K., Freeman, V. Frost, S.D.W. (2007) Hepatitis C virus and alanine aminotransferase kinetics following B-lymphocyte depletion with rituximab: evidence for a significant role of humoral immunity in the control of viremia in chronic HCV liver disease. Blood, 109, 845 846.
4. Magy, N., Cribier, B., Schmitt, C., Ellero, B., Jaeck, D., Boudjema, K., Wolf, P., Labouret, N., Doffoel, M., Kirn, A. Stoll-Kelleret, F. (1999) Effects of corticosteroids on HCV infection. International Journal of Immunopharmacology, 21, 253 261.
5. Rumi, M.G., De Filippi, F., La Vecchia, C., Donato, M.F., Gallus, S., Del Ninno, E. Colombo, M. (2005) Hepatitis C reactivation in patients with chronic infection with genotypes 1b and 2c: a retrospective cohort study of 206 untreated patients. Gut, 54, 402 406.
6. Sheen, I.S., Liaw, Y.F., Lin, D.Y. Chu, C.M. (1996) Acute exacerbations in chronic hepatitis C: a clinicopathological and prognostic study. Journal of Hepatology, 24, 525 531.